Showing results (31-40 of 247) with videos related to
Sort By:
Pageof 25
The FEBS Journal|July 8, 2024
Mapping the IMiD-dependent cereblon interactome using BioID-proximity labellingMatteo Costacurta, Jarrod J Sandow, Belinda Maher, et al.Nature Reviews. Drug Discovery|September 7, 2006
Anticancer activities of histone deacetylase inhibitorsJessica E Bolden, Melissa J Peart, Ricky W JohnstoneNature Reviews. Cancer|September 25, 2008
The TRAIL apoptotic pathway in cancer onset, progression and therapyRicky W Johnstone, Ailsa J Frew, Mark J SmythCancer Letters|April 11, 2009
Enhancing the apoptotic and therapeutic effects of HDAC inhibitorsAilsa J Frew, Ricky W Johnstone, Jessica E BoldenFuture Oncology (London, England)|June 13, 2009
Panobinostat (LBH589): a potent pan-deacetylase inhibitor with promising activity against hematologic and solid tumorsH Miles Prince, Mark J Bishton, Ricky W JohnstoneOncoimmunology|April 5, 2014
The anticancer effects of HDAC inhibitors require the immune systemAlison C West, Mark J Smyth, Ricky W JohnstoneCell|February 8, 2002
Apoptosis: a link between cancer genetics and chemotherapyRicky W Johnstone, Astrid A Ruefli, Scott W LoweExpert Opinion on Investigational Drugs|April 28, 2007
Histone deacetylase inhibitors in cancer therapyWalid K Rasheed, Ricky W Johnstone, H Miles PrinceCancer Cell|January 18, 2014
From anecdote to targeted therapy: the curious case of thalidomide in multiple myelomaJonathan D Licht, Jake Shortt, Ricky JohnstoneBlood|January 14, 2014
Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitorsMichael Bots, Inge Verbrugge, Benjamin P Martin, et al.Pageof 25